DNA methyltransferase inhibitors induce a BRCAness phenotype that sensitizes NSCLC to PARP inhibitor and ionizing radiation

A minority of cancers have breast cancer gene (BRCA) mutations that confer sensitivity to poly (ADP-ribose) polymerase (PARP) inhibitors (PARPis), but the role for PARPis in BRCA-proficient cancers is not well established. This suggests the need for novel combination therapies to expand the use of t...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Proc Natl Acad Sci U S A
Egile Nagusiak: Abbotts, Rachel, Topper, Michael J., Biondi, Christopher, Fontaine, Daniel, Goswami, Reena, Stojanovic, Lora, Choi, Eun Yong, McLaughlin, Lena, Kogan, Aksinija A., Xia, Limin, Lapidus, Rena, Mahmood, Javed, Baylin, Stephen B., Rassool, Feyruz V.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: National Academy of Sciences 2019
Gaiak:
Biological Sciences
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6842607/
https://ncbi.nlm.nih.gov/pubmed/31591209
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1903765116
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak